Willingness to get the COVID-19 vaccine with and without emergency use authorization
- PMID: 33227323
- PMCID: PMC7677682
- DOI: 10.1016/j.ajic.2020.11.018
Willingness to get the COVID-19 vaccine with and without emergency use authorization
Abstract
Background: This study assessed psychosocial predictors of U.S. adults' willingness to get a future COVID-19 vaccine and whether these predictors differ under an emergency use authorization (EUA) release of the vaccine.
Methods: A survey of 788 U.S. adults was conducted to explore the relationships between demographics and psychosocial predictors of intent to get a future COVID-19 vaccine as well as willingness to get such a vaccine under EUA.
Results: Significant predictors of COVID-19 vaccine uptake intentions were education, having insurance, scoring high on subjective norms, a positive attitude toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, scoring low on barriers to the vaccine, and scoring high on self-efficacy. Predictors of willingness to take a COVID-19 vaccine under EUA were age, race/ethnicity, positive subjective norms, high perceived behavioral control, positive attitudes toward the vaccine, as well as high perceived susceptibility to COVID-19, high perceived benefits of the vaccine, low barriers to the vaccine, and scoring high on self-efficacy for getting the vaccine. Concerns about rushed vaccine development appear to reduce vaccine uptake intent, as well as willingness to get the vaccine under EUA.
Conclusions: COVID-19 vaccine-related messages should both address concerns about the vaccine and its development and reinforce benefits of the vaccine (both factors significant in both models). Vaccine efforts may need to go beyond just communications campaigns correcting misinformation about a COVID-19 vaccine to also focus on re-establishing public trust in government agencies.
Keywords: Health Belief Model; Theory of planned behavior.
Copyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.PLoS One. 2021 Aug 23;16(8):e0256496. doi: 10.1371/journal.pone.0256496. eCollection 2021. PLoS One. 2021. PMID: 34424913 Free PMC article.
-
Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 - March 29, 2021.Ann Med. 2021 Dec;53(1):1419-1428. doi: 10.1080/07853890.2021.1957998. Ann Med. 2021. PMID: 34482788 Free PMC article.
-
Predictors of COVID-19 vaccine intentions in the United States: the role of psychosocial health constructs and demographic factors.Transl Behav Med. 2021 Sep 15;11(9):1782-1788. doi: 10.1093/tbm/ibab102. Transl Behav Med. 2021. PMID: 34293163 Free PMC article.
-
Using structural equation modeling to predict Indian people's attitudes and intentions towards COVID-19 vaccination.Diabetes Metab Syndr. 2021 May-Jun;15(3):1017-1022. doi: 10.1016/j.dsx.2021.05.006. Epub 2021 May 8. Diabetes Metab Syndr. 2021. PMID: 34000711 Free PMC article.
-
Public Willingness to Mask and Vaccinate in the Future: Results From a 2023 Nationally Representative Survey of US Adults.Health Secur. 2024 Aug;22(4):311-323. doi: 10.1089/hs.2023.0136. Health Secur. 2024. PMID: 39172114 Free PMC article.
Cited by
-
Medical mistrust, discrimination, and COVID-19 vaccine behaviors among a national sample U.S. adults.SSM Popul Health. 2022 Nov 12;20:101278. doi: 10.1016/j.ssmph.2022.101278. eCollection 2022 Dec. SSM Popul Health. 2022. PMID: 36407121 Free PMC article.
-
To Vaccinate or Not to Vaccinate-Reasons of Willingness and Reluctance of Students against SARS-CoV-2 Vaccination-An International Experience.Int J Environ Res Public Health. 2022 Oct 27;19(21):14012. doi: 10.3390/ijerph192114012. Int J Environ Res Public Health. 2022. PMID: 36360893 Free PMC article.
-
Vaccine hunters and jostlers may have hurt the COVID-19 vaccination effort.Sci Rep. 2022 Apr 16;12(1):6382. doi: 10.1038/s41598-022-10348-z. Sci Rep. 2022. PMID: 35430581 Free PMC article.
-
Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines.Vaccines (Basel). 2021 Oct 4;9(10):1129. doi: 10.3390/vaccines9101129. Vaccines (Basel). 2021. PMID: 34696237 Free PMC article. Review.
-
Perceived facilitators and barriers to intentions of receiving the COVID-19 vaccines among elderly Chinese adults.Vaccine. 2022 Jan 3;40(1):100-106. doi: 10.1016/j.vaccine.2021.11.039. Epub 2021 Nov 19. Vaccine. 2022. PMID: 34839994 Free PMC article.
References
-
- World Health Organization . 2020. Coronavirus Disease (COVID-19)https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... Available at:
-
- Bults M, Beaujean DJ, Richardus JH, Voeten HA. Perceptions and behavioral responses of the general public during the 2009 influenza A (H1N1) pandemic: a systematic review. Disast Med Public Health Preparedness. 2015;9:207–219. - PubMed
-
- Bostock B. 2020. Fauci Said it Will Take 12 to 18 Months to Get a Coronavirus Vaccine in the US. Experts Say a Quick Approval Could Be Risky.https://www.businessinsider.com/coronavirus-vaccine-quest-18-months-fauc... Available at:
-
- Le TT, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;1:305–306. - PubMed
-
- Soucheray S. 2020. Phase 3 Trial for Moderna COVID-19 Vaccine Begins Amid US Summer Surge.https://www.cidrap.umn.edu/news-perspective/2020/07/phase-3-trial-modern... Available at:
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical